BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 2513573)

  • 1. Overexpression of src family gene for tyrosine-kinase p59fyn in CD4-CD8- T cells of mice with a lymphoproliferative disorder.
    Katagiri T; Urakawa K; Yamanashi Y; Semba K; Takahashi T; Toyoshima K; Yamamoto T; Kano K
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10064-8. PubMed ID: 2513573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of lineage-restricted protein tyrosine kinase genes in human natural killer cells.
    Biondi A; Paganin C; Rossi V; Benvestito S; Perlmutter RM; Mantovani A; Allavena P
    Eur J Immunol; 1991 Mar; 21(3):843-6. PubMed ID: 1826268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allotment of protein-tyrosine kinases belonging to the src-family.
    Toyoshima K; Yamanashi Y; Inoue K; Katagiri T; Sukegawa J; Semba K; Yamamoto T
    Adv Second Messenger Phosphoprotein Res; 1990; 24():284-9. PubMed ID: 1698408
    [No Abstract]   [Full Text] [Related]  

  • 4. Suppression of autoimmune disease and of massive lymphadenopathy in MRL/Mp-lpr/lpr mice lacking tyrosine kinase Fyn (p59fyn).
    Takahashi T; Yagi T; Kakinuma S; Kurokawa A; Okada T; Takatsu K; Aizawa S; Katagiri T
    J Immunol; 1997 Sep; 159(5):2532-41. PubMed ID: 9278347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of hyporesponsiveness in lpr CD4-CD8- T cells is achieved by induction of cell cycling and normalization of CD2 and p59fyn expression.
    Clements JL; Wolfe J; Cooper SM; Budd RC
    Eur J Immunol; 1994 Mar; 24(3):558-65. PubMed ID: 7510235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential involvement of protein tyrosine kinases p56lck and p59fyn in T cell development.
    van Oers NS; Garvin AM; Cooke MP; Davis CB; Littman DR; Perlmutter RM; Teh HS
    Adv Exp Med Biol; 1992; 323():89-99. PubMed ID: 1485568
    [No Abstract]   [Full Text] [Related]  

  • 7. Oncogene expression in autoimmune mice.
    Mountz JD; Mushinski JF; Mark GE; Steinberg AD
    J Mol Cell Immunol; 1985; 2(3):121-31. PubMed ID: 3916923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional coupling of the src-family protein tyrosine kinases p59fyn and p53/56lyn with the interleukin 2 receptor: implications for redundancy and pleiotropism in cytokine signal transduction.
    Kobayashi N; Kono T; Hatakeyama M; Minami Y; Miyazaki T; Perlmutter RM; Taniguchi T
    Proc Natl Acad Sci U S A; 1993 May; 90(9):4201-5. PubMed ID: 8483935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Src-family protein tyrosine kinase transcription during lymphocyte ontogeny.
    Longo NS; Wang X; Wildin RS; Abraham KM
    Mol Immunol; 1999; 36(15-16):979-92. PubMed ID: 10698302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proliferative in vivo activities of lpr double-negative T cells and the primary role of p59fyn in their activation and expansion.
    Balomenos D; Rumold R; Theofilopoulos AN
    J Immunol; 1997 Sep; 159(5):2265-73. PubMed ID: 9278315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cells expressing receptors of different affinity for antigen ligands reveal a unique role for p59fyn in T cell development and optimal stimulation of T cells by antigen.
    Utting O; Teh SJ; Teh HS
    J Immunol; 1998 Jun; 160(11):5410-9. PubMed ID: 9605142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fyn can partially substitute for Lck in T lymphocyte development.
    Groves T; Smiley P; Cooke MP; Forbush K; Perlmutter RM; Guidos CJ
    Immunity; 1996 Nov; 5(5):417-28. PubMed ID: 8934569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An octapeptide analogue of HIV gp120 modulates protein tyrosine kinase activity in activated peripheral blood T lymphocytes.
    Phipps DJ; Reed-Doob P; MacFadden DK; Piovesan JP; Mills GB; Branch DR
    Clin Exp Immunol; 1995 Jun; 100(3):412-8. PubMed ID: 7539724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired development of CD4+ CD8+ thymoyctes by csk-'knock-in' into fyn locus.
    Kanazawa S; Ilic D; Hashiyama M; Okada M; Noumura T; Aizawa S; Suda T
    Oncogene; 1996 Jul; 13(1):199-204. PubMed ID: 8700547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of p56lck and p59fyn are reduced by a glucocorticoid-dependent mechanism in graft-versus-host reaction-induced T cell anergy.
    Desbarats J; You-Ten KE; Lapp WS
    Cell Immunol; 1995 Jun; 163(1):10-8. PubMed ID: 7758119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective thymocyte maturation by transgenic expression of a truncated form of the T lymphocyte adapter molecule and Fyn substrate, Sin.
    Donlin LT; Roman CA; Adlam M; Regelmann AG; Alexandropoulos K
    J Immunol; 2002 Dec; 169(12):6900-9. PubMed ID: 12471123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between the tyrosine kinases p56lck, p59fyn and p50csk in CD4 signaling in T cells.
    Baldari CT; Di Somma MM; Milia E; Bergman M; Telford JL
    Eur J Immunol; 1995 Apr; 25(4):919-25. PubMed ID: 7737294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Cbl proto-oncogene product negatively regulates the Src-family tyrosine kinase Fyn by enhancing its degradation.
    Andoniou CE; Lill NL; Thien CB; Lupher ML; Ota S; Bowtell DD; Scaife RM; Langdon WY; Band H
    Mol Cell Biol; 2000 Feb; 20(3):851-67. PubMed ID: 10629042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human airway epithelial cells stimulate T-lymphocyte lck and fyn tyrosine kinase.
    Kalb TH; Yio XY; Mayer L
    Am J Respir Cell Mol Biol; 1997 Nov; 17(5):561-70. PubMed ID: 9374107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of p56lck and p59fyn protein expression in thymocyte subsets, peripheral T cells, NK cells, and lymphoid cell lines.
    Olszowy MW; Leuchtmann PL; Veillette A; Shaw AS
    J Immunol; 1995 Nov; 155(9):4236-40. PubMed ID: 7594580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.